Just in time for procrastinators, FDA offers DRLS crash course
This article was originally published in The Gold Sheet
FDA is offering a one-hour crash course June 26 on how to use its new electronic drug registration and listing system (DRLS). The course is designed specifically for people with a pressing need to use the system, but who were caught unawares by the agency's decision to stop accepting paper applications June 1. FDA's Data Standards Council has been offering free six-session webinars, and will run those through September. For more information or to register, email email@example.com. Also on June 1, the agency published final guidance on filing electronic registration and listing submissions, available at www.fda.gov/cder/guidance
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.